ArticleCirculation. Heart failure2020
Psychosocial Risk and Its Association With Outcomes in Continuous-Flow Left Ventricular Assist Device Patients.
Article in Circulation. Heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Influence of Social Determinants of Health on Heart Failure Outcomes: A Systematic Review.Journal of the American Heart Association · 2023Pooled it
- Association between psychosocial factors and left ventricular assist device implant outcomes: A systematic review.General hospital psychiatryPooled it
- Curricular Self-management for patients on ventricular assist device support decreases depression: A multicenter randomized controlled trial.Artificial organs · 2025Trial
- Transforming Advanced Heart Failure Programs: Addressing Institutional and Systemic Drivers of Racial and Ethnic Disparities in Care.Circulation. Heart failure · 2026Review
- Depression and Suicidality in Patients with Left Ventricular Assist Devices and Advanced Cardiac Therapies: Mechanisms, Risk Factors, and Clinical Management.Medical sciences (Basel, Switzerland) · 2026Review
- Social contributions as risk factors for readmissions after lung transplantation: Clinical and financial implications.JHLT open · 2025Article
- Psychosocial Risk and Recurrent Hospitalizations in Women and Men Following LVAD Implantation: A Multi-State Analysis of the INTERMACS Registry.Journal of cardiovascular development and disease · 2025Article
- Association of Psychosocial Risk Factors With Quality of Life and Readmissions 1 Year After LVAD Implantation.Journal of cardiac failure · 2025Article
- Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries.Life (Basel, Switzerland) · 2024Article
- Socio-economic position, multimorbidity, and health care utilization among Danish left ventricular assist device patients.ESC heart failure · 2024Article
- The Influence of Arrhythmias and Metabolic Profile on Inpatient Mortality in Patients with Left Ventricular Assist Devices.Journal of clinical medicine · 2024Article
- Impairments identified by comprehensive geriatric assessment in potential candidates for left ventricular assist device and heart transplantation.International journal of cardiology. Heart & vasculature · 2024Article
- Impact of Psychosocial Risk Factors on Outcomes of Atrial Fibrillation Patients undergoing Left Atrial Appendage Occlusion Device Implantation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023Article
- How to Select Patients for Left Ventricular Assist Devices? A Guide for Clinical Practice.Journal of clinical medicine · 2023Review
- How to select a patient for LVAD.Indian journal of thoracic and cardiovascular surgery · 2023Review
- Commentary: How to predict a harmonious relationship between patients and their left ventricular assist device?The Journal of thoracic and cardiovascular surgery · 2023Article
- The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support.Journal of clinical medicine · 2022Review
- Need for Unstructured Preimplantation Data to Predict Myocardial Recovery in Patients With a Left Ventricular Assist Device.Journal of the American Heart Association · 2022Article
- Sex Differences in Recovery and Device Replacement After Left Ventricular Assist Device Implantation as Destination Therapy.Journal of the American Heart Association · 2022Article
- The impact of socioeconomic status in patients with left ventricular assist devices (LVADs).Journal of cardiac surgery · 2021Article
Corrections and comments
- Commented on by
Authors and funding
13 authors.
Funding
Abstract
backgroundAdvanced heart failure therapies such as left ventricular assist device (LVAD) implantation require intricate follow-up and complex care. We sought to explore the burden of psychosocial risk factors among patients with LVAD and their impact on postimplant outcomes using the Interagency Registry for Mechanically Assisted Circulatory Support.
methodsAdult patients in the Interagency Registry for Mechanically Assisted Circulatory Support requiring durable LVAD between 2008 and 2017 were included. Individuals were determined to have psychosocial risk if they had one of the following: (1) limited social support; (2) limited cognition; (3) substance abuse (alcohol and drug); (4) severe psychiatric disease (including major depression and other major psychiatric diagnosis); and (5) repeated noncompliance. Univariate and multivariate Cox proportional hazard regression models were used to analyze predictors of survival and complications.
resultsA total of 15 403 continuous-flow LVAD recipients were included. A total of 3163 (20.5%) had one or more psychosocial risk factors. The most prevalent psychosocial risk factor was substance abuse in 1941 (12.6%) recipients. Patients with psychosocial risk factors were significantly younger at LVAD implant, less likely to be White, and less likely to be female compared with those without psychosocial risk,
conclusionsPsychosocial risk is an important component of patient selection for advanced heart failure therapies. Addressing these specific components may help improve access to advanced therapies and post-LVAD outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.